Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Drug Discovery Informatics Market Forecast: What Value Will The Market Reach By 2030?
The drug discovery informatics market has shown rapid expansion in recent years. This market is projected to expand from $4.06 billion in 2025 to $4.63 billion in 2026, registering a compound annual growth rate (CAGR) of 14.1%. The historical growth in this sector can be attributed to factors such as increasing pharmaceutical R&D complexity, the growing volume of clinical trial data, the adoption of computational chemistry tools, the rise in bioinformatics applications, and the escalating demand for faster drug development cycles.
The drug discovery informatics market is anticipated to experience substantial expansion in the coming years. It is projected to reach $7.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.7%. This projected growth during the forecast timeframe is attributable to a surge in investments towards AI-enabled drug discovery, the increasing uptake of precision medicine strategies, the broadening of collaborative research frameworks, a heightened emphasis on the precision of predictive modeling, and the deeper integration of informatics with laboratory infrastructure. Key trends expected during the forecast period encompass the expanding utilization of AI-powered drug discovery platforms, the growing embrace of cloud-based informatics tools, the deepening incorporation of big data analytics within research and development, the proliferation of virtual screening and modeling instruments, and an elevated commitment to data integration and stewardship.
Get A Free Sample Report With In-Depth Market Insights:
Drug Discovery Informatics Market Growth Momentum: What Factors Are Shaping Demand?
The expanding occurrence of various chronic diseases is anticipated to fuel the growth of the drug discovery informatics market moving forward. These conditions are generally defined as disorders that persist for a year or longer, necessitating continuous medical attention, obstructing daily activities, or both. Drug discovery informatics systems play a crucial role in advancing chronic illness care by enabling researchers to investigate intricate and transient molecular alterations underlying disease progression and drug response, thereby developing multi-dimensional models of the entire hierarchical system across healthy, diseased, and treated conditions. For example, in May 2024, the British Diabetic Association (Diabetes UK), a UK-based patient, healthcare professional, and research charity, reported that approximately 4.4 million people in the UK were diagnosed with diabetes as of 2022-23. Of these individuals, roughly 8% suffered from type 1 diabetes, while type 2 diabetes constituted about 90%. Consequently, the increasing prevalence of various chronic diseases is propelling the expansion of the drug discovery informatics market.
Drug Discovery Informatics Market Segment Analysis: What Are The Core Market Categories?
The drug discovery informatics market covered in this report is segmented –
1) By Service: In-House, Outsourced
2) By Application: Data Sequencing, Molecular Docking, Identification And Validation, Target Data Analysis
3) By End-User: Pharmaceutical Companies, Contract Research Organizations, Bio-Technology Companies
Subsegments:
1) By In-House: Data Management, Computational Chemistry, Bioinformatics, Cheminformatics, Predictive Modeling
2) By Outsourced: Contract Research Organizations (CROs), Specialized Informatics Providers, Data Analysis And Management Services
Drug Discovery Informatics Market Trends Redefining Industry Growth
Leading companies operating within the drug discovery informatics market are concentrating on innovative products, such as AI-powered life sciences solutions, to enhance their market revenues. Artificial intelligence (AI)-driven life sciences solutions are advancing precision medicine and drug discovery, with the potential to completely transform the creation of novel therapies and individualized treatment plans, thereby improving the speed, precision, and efficiency of the life sciences industry’s research and development procedures. For instance, in May 2023, Google Cloud Platform, a US-based technology company, launched AI-powered life sciences solutions, including a target and lead identification suite and a multiomics suite. These are intended to revolutionize life sciences companies by speeding up drug research and accelerating the release of new treatments. These methods anticipate protein structures, determine the role of amino acids, and analyze genetic data by utilizing high-performance computers, generative AI, and sophisticated computational tools. The multiomics suite aids in the development of precision medicine tools, and the target and lead identification suite facilitates more effective in silico drug design.
Drug Discovery Informatics Market Top Companies Driving Competitive Growth
Major companies operating in the drug discovery informatics market are Accenture Plc.; Certara Inc.; Charles River Laboratories Inc.; Infosys Ltd.; Collaborative Drug Discovery Inc.; Eurofins DiscoverX Products Inc.; Jubilant Biosys Ltd.; Selvita S.A.; PerkinElmer Inc.; International Business Machines Corporation; Boehringer Ingelheim International GmbH; Oracle Corporation; Thermo Fisher Scientific Inc.; Albany Molecular Research Inc.; ChemAxon Ltd.; Amazon Web Services Inc.; Schrödinger LLC.; Core Informatics LLC; Informatics Matters Ltd.; Tata Consultancy Services Limited; Novo Informatics Pvt. Ltd.; IO Informatics Inc.; GVK Biosciences Private Limited; Dassault Systèmes SE; Recursion Pharmaceuticals Inc.; Cyclica Inc.; Valence Discovery Inc.; Valo Health Inc.; Cognizant Technology Solutions Corporation; Wipro Limited; Mindtree Limited; Persistent Systems Limited; Mphasis Limited
View The Full Drug Discovery Informatics Market Report:
Drug Discovery Informatics Market Top Region By Revenue And Market Share
North America was the largest region in the drug discover informatics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
